Items where authors include "Kishore, B."

Article

Kaparou, M., Rudzki, Z., Giles, H. et al. (16 more authors) (2021) Management of allogeneic stem cell transplantation for high-risk AML following SARS-CoV-2 associated pancytopenia with marked bone marrow biopsy alterations. Case Reports in Hematology, 2021. 8843063. ISSN 2090-6560

Jackson, G.H., Pawlyn, C., Cairns, D.A. et al. (20 more authors) (2021) Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial. PLOS Medicine, 18 (1). e1003454. ISSN 1549-1277

Kanellopoulos, A. orcid.org/0000-0002-7400-5416, Ahmed, M.Z., Kishore, B. et al. (15 more authors) (2020) COVID‐19 in bone marrow transplant recipients : reflecting on a single centre experience. British Journal of Haematology, 190 (2). e67-e70. ISSN 0007-1048

Horgan, C., Kartsios, C., Nikolousis, E. et al. (13 more authors) (2020) First case of near haploid philadelphia negative B-Cell acute lymphoblastic leukaemia relapsing as acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation. Leukemia Research Reports, 14. 100213. ISSN 2213-0489

McIlroy, G., Nikolousis, E., Abou-Zeid, N. et al. (9 more authors) (2020) Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based reduced-intensity allogeneic hematopoietic stem cell transplantation. Leukemia & Lymphoma, 61 (1). pp. 202-205. ISSN 1042-8194

Lloyd, R., Nikolousis, E., Kishore, B. et al. (11 more authors) (2020) Autoimmune cytopenias developing late post alemtuzumab-based allogeneic stem cell transplantation: presentation of short case series from a transplant center. Cell Transplantation, 29. ISSN 0963-6897

Horgan, C., Elmoamly, S., McIlroy, G. et al. (9 more authors) (2019) Reduced intensity alemtuzumab-containing allogeneic stem cell transplantation for relapsed/refractory low grade lymphoma : reflections on a single center experience. Leukemia & Lymphoma, 60 (12). pp. 3075-3077. ISSN 1042-8194

Galleu, A., Milojkovic, D., Deplano, S. et al. (21 more authors) (2019) Mesenchymal stromal cells for acute graft-versus-host disease: response at 1 week predicts probability of survival. British Journal of Haematology, 185 (1). pp. 89-92. ISSN 0007-1048

Horgan, C., Kanellopoulos, A., Paneesha, S. et al. (3 more authors) (2019) A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic stem cell transplant. Hematology Reports, 11 (1). 7800. ISSN 2038-8322

Schindler, S.D. and Kishore, B. (2015) Why Delhi cannot plan its ‘new towns’: The case of solid waste management in Noida. Geoforum, 60 (March ). 33 - 42 . ISSN 1872-9398

Proceedings Paper

Jackson, G.H., Davies, F.E., Pawlyn, C. et al. (18 more authors) (2016) Lenalidomide is a highly effective maintenance therapy in myeloma patients of all ages; results of the Phase III Myeloma XI Study. In: Blood. 58th ASH Annual Meeting, 03-06 Dec 2016, San Diego, CA, USA. American Society of Hematology .

Pawlyn, C., Davies, F.E., Kaiser, M.F. et al. (18 more authors) (2016) Primary IMiD refractory myeloma; results from 3894 patients treated in the Phase III Myeloma XI Study. In: Blood. 58th ASH Annual Meeting, 03-06 Dec 2016, San Diego, CA, USA. American Society of Hematology .

Jackson, G.H., Davies, F.E., Pawlyn, C. et al. (18 more authors) (2016) Response adapted induction treatment improves outcomes for myeloma patients; results of the Phase III Myeloma XI Study. In: Blood. 58th ASH Annual Meeting, 03-06 Dec 2016, San Diego, CA, USA. American Society of Hematology .